Condition
Ventilator-associated Bacterial Pneumonia (VABP) clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Ventilator-associated Bacterial Pneumonia (VABP) clinical trials that are recruiting, at sites in 3 countries (most in China (2), Georgia (1), Egypt (1)). By phase: Phase 3 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest Ventilator-associated Bacterial Pneumonia (VABP) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Ventilator Hyperinflation Plus Body Positioning to Improve Gas Exchange in VAP | — | Cairo | Recruiting | Oct 2, 2026 |
| ASK0912 versus Polymyxin B for severe hospital- or ventilator-associated pneumonia | Phase 2 | Nanjing, Jiangsu | Recruiting | Aug 12, 2026 |
| BV100 plus low-dose polymyxin B versus colistin with high-dose ampicillin/sulbactam for hospital- or ventilator-associated pneumonia from carbapenem-resistant Acinetobacter | Phase 3 | Tbilisi | Recruiting | Jan 8, 2026 |
| Meropenem plus pralurbactam versus best available antibiotics for carbapenem‑resistant Enterobacteriaceae infections | Phase 3 | Shanghai | Recruiting | Jul 28, 2025 |
All recruiting trials (4)
-
Ventilator Hyperinflation Plus Body Positioning to Improve Gas Exchange in VAP
This study tests whether using ventilator hyperinflation together with different body positions can improve blood oxygen and other arterial blood gas measures in adults with ventilator-associated pneumonia.
-
ASK0912 versus Polymyxin B for severe hospital- or ventilator-associated pneumonia
A phase 2 study tests two dosing regimens of ASK0912 for injection against Polymyxin B in adults with HABP or VABP to see which works best with acceptable safety.
-
BV100 plus low-dose polymyxin B versus colistin with high-dose ampicillin/sulbactam for hospital- or ventilator-associated pneumonia from carbapenem-resistant Acinetobacter
This trial tests whether BV100 combined with low-dose polymyxin B helps adults with hospital- or ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter work better and be safer than colistin with high-dose ampicillin/sulbactam.
-
Meropenem plus pralurbactam versus best available antibiotics for carbapenem‑resistant Enterobacteriaceae infections
This test compares meropenem combined with pralurbactam to current best available antibiotics for adults hospitalized with serious infections caused by carbapenem‑resistant Enterobacteriaceae.
Related topics
Quick answers
How many Ventilator-associated Bacterial Pneumonia (VABP) clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (2 trials), Georgia (1 trial), Egypt (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.